Trial
NCT04571710
A Trial of SHR1258 in Patients With Biliary Tract Cancer
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Collaborators
—
Condition
Biliary Tract Cancer
Intervention
SHR1258
Why stopped
The sponsor's R\&D strategy is adjusted.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-24